Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has submitted schedule of investor meeting that the Company would be participating on 13 June 2024. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.
